IL319214A - Pharmaceutical formulation - Google Patents
Pharmaceutical formulationInfo
- Publication number
- IL319214A IL319214A IL319214A IL31921425A IL319214A IL 319214 A IL319214 A IL 319214A IL 319214 A IL319214 A IL 319214A IL 31921425 A IL31921425 A IL 31921425A IL 319214 A IL319214 A IL 319214A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2022116379 | 2022-08-31 | ||
| PCT/EP2023/073764 WO2024047094A1 (en) | 2022-08-31 | 2023-08-30 | Pharmaceutical formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL319214A true IL319214A (en) | 2025-04-01 |
Family
ID=87930216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL319214A IL319214A (en) | 2022-08-31 | 2023-08-30 | Pharmaceutical formulation |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240091231A1 (en) |
| EP (1) | EP4580606B1 (en) |
| JP (1) | JP2025527807A (en) |
| KR (1) | KR20250054108A (en) |
| CN (1) | CN119789849A (en) |
| AR (1) | AR130351A1 (en) |
| AU (1) | AU2023332020A1 (en) |
| CA (1) | CA3266275A1 (en) |
| IL (1) | IL319214A (en) |
| MX (1) | MX2025002184A (en) |
| TW (1) | TW202425997A (en) |
| WO (1) | WO2024047094A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026145414A1 (en) * | 2024-12-31 | 2026-07-09 | 石药集团中奇制药技术(石家庄)有限公司 | Pharmaceutical composition comprising tricyclic heteroaryl compound, preparation method therefor and use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
| US6524618B1 (en) * | 2001-06-12 | 2003-02-25 | Vijai Kumar | Directly compressible extended-release matrix formulation for metformin hydrochloride |
| HU227317B1 (en) * | 2003-11-25 | 2011-03-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Enteric coated tablet containing pantoprazole |
| GB0620005D0 (en) * | 2006-10-10 | 2006-11-22 | Glaxo Group Ltd | Compounds |
| US20090054468A1 (en) * | 2007-08-23 | 2009-02-26 | Astrazeneca Ab | New Use 938 |
| AU2013204533B2 (en) * | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
| US9616063B2 (en) * | 2014-12-01 | 2017-04-11 | Astrazeneca Ab | 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase |
| WO2017064814A1 (en) * | 2015-10-16 | 2017-04-20 | 持田製薬株式会社 | Dienogest-containing tablet |
| CN113645961A (en) * | 2019-03-13 | 2021-11-12 | 诺华股份有限公司 | Pharmaceutical composition |
| MX2022014901A (en) * | 2020-06-02 | 2023-01-18 | Nerre Therapeutics Ltd | Neurokinin (nk)-1 receptor antagonists for use in the treatment of pulmonary fibrosis conditions promoted by mechanical injury to the lungs. |
| TW202342040A (en) * | 2022-02-21 | 2023-11-01 | 瑞士商諾華公司 | Pharmaceutical formulation |
-
2023
- 2023-08-30 CN CN202380062323.0A patent/CN119789849A/en active Pending
- 2023-08-30 CA CA3266275A patent/CA3266275A1/en active Pending
- 2023-08-30 AU AU2023332020A patent/AU2023332020A1/en active Pending
- 2023-08-30 EP EP23764853.0A patent/EP4580606B1/en active Active
- 2023-08-30 IL IL319214A patent/IL319214A/en unknown
- 2023-08-30 KR KR1020257010289A patent/KR20250054108A/en active Pending
- 2023-08-30 JP JP2025512662A patent/JP2025527807A/en active Pending
- 2023-08-30 WO PCT/EP2023/073764 patent/WO2024047094A1/en not_active Ceased
- 2023-08-30 US US18/458,436 patent/US20240091231A1/en active Pending
- 2023-08-31 TW TW112132966A patent/TW202425997A/en unknown
- 2023-08-31 AR ARP230102312A patent/AR130351A1/en unknown
-
2025
- 2025-02-24 MX MX2025002184A patent/MX2025002184A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN119789849A (en) | 2025-04-08 |
| WO2024047094A1 (en) | 2024-03-07 |
| US20240091231A1 (en) | 2024-03-21 |
| EP4580606B1 (en) | 2026-05-27 |
| EP4580606A1 (en) | 2025-07-09 |
| TW202425997A (en) | 2024-07-01 |
| JP2025527807A (en) | 2025-08-22 |
| AR130351A1 (en) | 2024-11-27 |
| AU2023332020A1 (en) | 2025-04-17 |
| MX2025002184A (en) | 2025-04-02 |
| CA3266275A1 (en) | 2024-03-07 |
| KR20250054108A (en) | 2025-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290894A (en) | Pharmaceutical formulation | |
| EP4238556A4 (en) | Gastroretentive pharmaceutical dosage form | |
| IL300090A (en) | Pharmaceutical compositions comprising venglustat | |
| GB202010230D0 (en) | Pharmaceutical formulation | |
| IL327150A (en) | Pharmaceutical compositions | |
| GB202100526D0 (en) | Pharmaceutical formulation | |
| GB202005282D0 (en) | Pharmaceutical Formulations | |
| ZA202212663B (en) | Pharmaceutical formulations | |
| IL314206A (en) | Pharmaceutical formulation | |
| IL326970A (en) | Pharmaceutical compositions comprising nipocalimab | |
| GB202104097D0 (en) | Pharmaceutical compounds | |
| GB202307626D0 (en) | Pharmaceutical formulations | |
| IL297081A (en) | Pharmaceutical formulation | |
| CA3266275A1 (en) | Pharmaceutical formulation | |
| GB201906473D0 (en) | Pharmaceutical formulation | |
| IL314046A (en) | Ribociclib pharmaceutical compositions | |
| IL321640A (en) | Pharmaceutical formulation | |
| GB202216467D0 (en) | Pharmaceutical formulation | |
| GB202203764D0 (en) | Pharmaceutical formulation | |
| GB202003108D0 (en) | Pharmaceutical formulations | |
| IL289927A (en) | New pharmaceutical formulation | |
| GB202001439D0 (en) | Drug formulations | |
| GB202510537D0 (en) | Pharmaceutical formulation | |
| IL308250A (en) | Pharmaceutical formulations | |
| GB202112820D0 (en) | Pharmaceutical formulations |